The recent paradigm shift in disease treatment is autologous cell therapy using one's own cells.
Until now, humanity has mainly used highly toxic chemotherapy, such as anticancer drugs,
to treat cancers and other intractable diseases.
These treatments often come with extreme pain and severe side effects.
To overcome this, the world is rapidly developing immunotherapy using cells originally possessed by humans,
and many clinical trials and treatment cases are currently being reported.
As a cell therapy development company, BH Biotech takes pride in possessing the best cell culture technology specialized in immune cells and stem cells.
We aim to research and develop not only anticancer immunotherapies but also treatments for rare and intractable diseases.
BH Biotech will continuously pursue relentless research and development for the beautiful and healthy dream of extending human life,
and will emerge as a leader in the biotech industry.